Immunomodulatory effects of mesenchymal stem cells and mesenchymal stem cell-derived extracellular vesicles in rheumatoid arthritis
H Liu, R Li, T Liu, L Yang, G Yin, Q **e - Frontiers in Immunology, 2020 - frontiersin.org
Rheumatoid arthritis (RA) is a chronic autoimmune disease that affects the joints and other
organs for which there is currently no effective treatment. Mesenchymal stem cells (MSCs) …
organs for which there is currently no effective treatment. Mesenchymal stem cells (MSCs) …
Mesenchymal stem cell (MSC)-derived exosomes as novel vehicles for delivery of miRNAs in cancer therapy
B Sohrabi, B Dayeri, E Zahedi, S Khoshbakht… - Cancer Gene …, 2022 - nature.com
Mesenchymal stem cells (MSCs) are known as promising sources for cancer therapy and
can be utilized as vehicles in cancer gene therapy. MSC-derived exosomes are central …
can be utilized as vehicles in cancer gene therapy. MSC-derived exosomes are central …
Therapeutic strategy of mesenchymal-stem-cell-derived extracellular vesicles as regenerative medicine
Y Matsuzaka, R Yashiro - International Journal of Molecular Sciences, 2022 - mdpi.com
Extracellular vesicles (EVs) are lipid bilayer membrane particles that play critical roles in
intracellular communication through EV-encapsulated informative content, including …
intracellular communication through EV-encapsulated informative content, including …
Mesenchymal stem cells: from identification and characterization to clinical applications
M Alvarez-Viejo, KH Haider - Handbook of stem cell therapy, 2022 - Springer
Since Friedenstein and co-workers first reported bone marrow-derived mesenchymal stem
cells (MSCs) during the early 1970s, several researchers have focused on their biology and …
cells (MSCs) during the early 1970s, several researchers have focused on their biology and …
Small extracellular vesicles derived from MSCs have immunomodulatory effects to enhance delivery of ASO-210 for psoriasis treatment
W Zhang, J Lin, P Shi, D Su, X Cheng, W Yi… - Frontiers in cell and …, 2022 - frontiersin.org
Mesenchymal stem cells (MSCs) have been increasingly used for treating autoimmune
diseases due to their immune modulation functions, but inefficient homing to the target tissue …
diseases due to their immune modulation functions, but inefficient homing to the target tissue …
Concurrent hypoxia and apoptosis imparts immune programming potential in mesenchymal stem cells: Lesson from acute graft-versus-host-disease model
M Mendiratta, M Mendiratta, S Ganguly, S Rai… - Stem Cell Research & …, 2024 - Springer
Abstract Background Mesenchymal stem cells (MSCs) have emerged as promising
candidates for immune modulation in various diseases that are associated with …
candidates for immune modulation in various diseases that are associated with …
Mesenchymal stromal cells enhance vascularization and epithelialization within 7 days after gingival augmentation with collagen matrices in rabbits
A Kulakov, E Kogan, T Brailovskaya, A Vedyaeva… - Dentistry Journal, 2021 - mdpi.com
Soft gingival tissue deficiency remains a severe problem leading to postoperative recession,
peri-implantitis, and bone resorption. The use of collagen matrices does not always lead to …
peri-implantitis, and bone resorption. The use of collagen matrices does not always lead to …
Alloreactive immune response associated to human mesenchymal stromal cells treatment: a systematic review
R Sanabria-de la Torre, MI Quiñones-Vico… - Journal of Clinical …, 2021 - mdpi.com
The well-known immunomodulatory and regenerative properties of mesenchymal stromal
cells (MSCs) are the reason why they are being used for the treatment of many diseases …
cells (MSCs) are the reason why they are being used for the treatment of many diseases …
Understanding and treatment of cutaneous graft-versus-host-disease
J Hong, J Fraebel, Y Yang, E Tkacyk, C Kitko… - Bone Marrow …, 2023 - nature.com
The skin is the outermost mechanical barrier where dynamic immune reactions take place
and is the most commonly affected site in both acute and chronic graft-versus-host disease …
and is the most commonly affected site in both acute and chronic graft-versus-host disease …
Cord blood plasma and placental mesenchymal stem cells-derived exosomes increase ex vivo expansion of human cord blood hematopoietic stem cells while …
Background: Mesenchymal stem cells (MSCs) have been used for ex vivo expansion of
umbilical cord blood (UCB) hematopoietic stem cells (HSCs) to maintain their primitive …
umbilical cord blood (UCB) hematopoietic stem cells (HSCs) to maintain their primitive …